These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
491 related articles for article (PubMed ID: 23481040)
1. p70S6 kinase is a target of the novel proteasome inhibitor 3,3'-diamino-4'-methoxyflavone during apoptosis in human myeloid tumor cells. Piedfer M; Bouchet S; Tang R; Billard C; Dauzonne D; Bauvois B Biochim Biophys Acta; 2013 Jun; 1833(6):1316-28. PubMed ID: 23481040 [TBL] [Abstract][Full Text] [Related]
2. Hyperforin inhibits Akt1 kinase activity and promotes caspase-mediated apoptosis involving Bad and Noxa activation in human myeloid tumor cells. Merhi F; Tang R; Piedfer M; Mathieu J; Bombarda I; Zaher M; Kolb JP; Billard C; Bauvois B PLoS One; 2011; 6(10):e25963. PubMed ID: 21998731 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of panobinostat and marizomib in acute myeloid leukemia and bortezomib-resistant models. Corrales-Medina FF; Manton CA; Orlowski RZ; Chandra J Leuk Res; 2015 Mar; 39(3):371-9. PubMed ID: 25612941 [TBL] [Abstract][Full Text] [Related]
4. Proteasome inhibitor-induced apoptosis in acute myeloid leukemia: a correlation with the proteasome status. Matondo M; Bousquet-Dubouch MP; Gallay N; Uttenweiler-Joseph S; Recher C; Payrastre B; Manenti S; Monsarrat B; Burlet-Schiltz O Leuk Res; 2010 Apr; 34(4):498-506. PubMed ID: 19811823 [TBL] [Abstract][Full Text] [Related]
5. Proteasome inhibitors potentiate leukemic cell apoptosis induced by the cyclin-dependent kinase inhibitor flavopiridol through a SAPK/JNK- and NF-kappaB-dependent process. Dai Y; Rahmani M; Grant S Oncogene; 2003 Oct; 22(46):7108-22. PubMed ID: 14562039 [TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitor depsipeptide (FK228) induces apoptosis in leukemic cells by facilitating mitochondrial translocation of Bax, which is enhanced by the proteasome inhibitor bortezomib. Sutheesophon K; Kobayashi Y; Takatoku MA; Ozawa K; Kano Y; Ishii H; Furukawa Y Acta Haematol; 2006; 115(1-2):78-90. PubMed ID: 16424655 [TBL] [Abstract][Full Text] [Related]
7. The effect of the proteasome inhibitor bortezomib on acute myeloid leukemia cells and drug resistance associated with the CD34+ immature phenotype. Colado E; Alvarez-Fernández S; Maiso P; Martín-Sánchez J; Vidriales MB; Garayoa M; Ocio EM; Montero JC; Pandiella A; San Miguel JF Haematologica; 2008 Jan; 93(1):57-66. PubMed ID: 18166786 [TBL] [Abstract][Full Text] [Related]
8. Bortezomib-induced sensitization of malignant human glioma cells to vorinostat-induced apoptosis depends on reactive oxygen species production, mitochondrial dysfunction, Noxa upregulation, Mcl-1 cleavage, and DNA damage. Premkumar DR; Jane EP; Agostino NR; DiDomenico JD; Pollack IF Mol Carcinog; 2013 Feb; 52(2):118-33. PubMed ID: 22086447 [TBL] [Abstract][Full Text] [Related]
9. Cooperative cytotoxicity of proteasome inhibitors and tumor necrosis factor-related apoptosis-inducing ligand in chemoresistant Bcl-2-overexpressing cells. Nencioni A; Wille L; Dal Bello G; Boy D; Cirmena G; Wesselborg S; Belka C; Brossart P; Patrone F; Ballestrero A Clin Cancer Res; 2005 Jun; 11(11):4259-65. PubMed ID: 15930365 [TBL] [Abstract][Full Text] [Related]
10. TM-233, a novel analog of 1'-acetoxychavicol acetate, induces cell death in myeloma cells by inhibiting both JAK/STAT and proteasome activities. Sagawa M; Tabayashi T; Kimura Y; Tomikawa T; Nemoto-Anan T; Watanabe R; Tokuhira M; Ri M; Hashimoto Y; Iida S; Kizaki M Cancer Sci; 2015 Apr; 106(4):438-46. PubMed ID: 25613668 [TBL] [Abstract][Full Text] [Related]
11. [Reversal effect of LBH589 alone or in combination with bortezomib on drug-resistance in myeloid leukemia and its mechanism]. Jiang XJ; Meng FY; Zhou HS; Wang Q; Wu FQ; Huang KK; Huang M; Wang ZX; Chen WW Zhonghua Xue Ye Xue Za Zhi; 2011 Aug; 32(8):537-42. PubMed ID: 22338177 [TBL] [Abstract][Full Text] [Related]
12. [Apoptosis of myeloid leukemia cell line HL60 induced by Bortezomib, a proteasome inhibitor]. Fu YB; Sun QX; Meng FY; Xie J; Zhou GB Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(34):2413-6. PubMed ID: 17156654 [TBL] [Abstract][Full Text] [Related]
13. Bortezomib-mediated downregulation of S-phase kinase protein-2 (SKP2) causes apoptotic cell death in chronic myelogenous leukemia cells. Iskandarani A; Bhat AA; Siveen KS; Prabhu KS; Kuttikrishnan S; Khan MA; Krishnankutty R; Kulinski M; Nasr RR; Mohammad RM; Uddin S J Transl Med; 2016 Mar; 14():69. PubMed ID: 26956626 [TBL] [Abstract][Full Text] [Related]
14. Effects of the proteasome inhibitor, bortezomib, on apoptosis in isolated lymphocytes obtained from patients with chronic lymphocytic leukemia. Pahler JC; Ruiz S; Niemer I; Calvert LR; Andreeff M; Keating M; Faderl S; McConkey DJ Clin Cancer Res; 2003 Oct; 9(12):4570-7. PubMed ID: 14555532 [TBL] [Abstract][Full Text] [Related]
15. Proteasome inhibition specifically sensitizes leukemic cells to anthracyclin-induced apoptosis through the accumulation of Bim and Bax pro-apoptotic proteins. Pigneux A; Mahon FX; Moreau-Gaudry F; Uhalde M; de Verneuil H; Lacombe F; Reiffers J; Milpied N; Praloran V; Belloc F Cancer Biol Ther; 2007 Apr; 6(4):603-11. PubMed ID: 17374988 [TBL] [Abstract][Full Text] [Related]
16. Bortezomib sensitivity of acute myeloid leukemia CD34(+) cells can be enhanced by targeting the persisting activity of NF-κB and the accumulation of MCL-1. Bosman MC; Schuringa JJ; Quax WJ; Vellenga E Exp Hematol; 2013 Jun; 41(6):530-538.e1. PubMed ID: 23416210 [TBL] [Abstract][Full Text] [Related]
17. Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells. Rao J; Xu DR; Zheng FM; Long ZJ; Huang SS; Wu X; Zhou WH; Huang RW; Liu Q J Transl Med; 2011 May; 9():71. PubMed ID: 21595920 [TBL] [Abstract][Full Text] [Related]
18. Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors. Pei XY; Dai Y; Grant S Clin Cancer Res; 2004 Jun; 10(11):3839-52. PubMed ID: 15173093 [TBL] [Abstract][Full Text] [Related]
19. Bortezomib interacts synergistically with belinostat in human acute myeloid leukaemia and acute lymphoblastic leukaemia cells in association with perturbations in NF-κB and Bim. Dai Y; Chen S; Wang L; Pei XY; Kramer LB; Dent P; Grant S Br J Haematol; 2011 Apr; 153(2):222-35. PubMed ID: 21375523 [TBL] [Abstract][Full Text] [Related]
20. A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells. Martelli AM; Tazzari PL; Tabellini G; Bortul R; Billi AM; Manzoli L; Ruggeri A; Conte R; Cocco L Leukemia; 2003 Sep; 17(9):1794-805. PubMed ID: 12970779 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]